Navigation Links
Gonorrhea's Growing Resistance to Antibiotics Concerns CDC
Date:7/7/2011

THURSDAY, July 7 (HealthDay News) -- Gonorrhea appears to be growing increasingly resistant to drugs called cephalosporins, the only remaining class of antibiotics available to treat the sexually transmitted disease, according to a new report.

Researchers analyzed 10 years' worth of gonorrhea samples (isolates) from men in 30 U.S. cities. The samples were collected between January 2000 and June 2010 through the U.S. Centers for Disease Control and Prevention's Gonococcal Isolate Surveillance Project.

The analysis revealed an increase in the proportion of samples with elevated minimum inhibitory concentrations (MICs), the lowest concentration of antibiotics needed to halt the growth of gonorrhea bacteria. These increases in MICs suggest a decline in gonorrhea's susceptibility to antibiotics, the researchers explained in a CDC news release.

During the study period, the percentage of gonorrhea samples exhibiting elevated MICs rose from 0.2 to 1.4 percent of samples for cefixime (an oral cephalosporin) and from 0.1 to 0.3 percent for ceftriaxone (an injectable cephalosporin).

To date, there are no recorded cases of patients with gonorrhea that couldn't be treated with these antibiotics in the United States.

The study is published in the July 8 edition of the CDC's Morbidity and Mortality Weekly Report.

The researchers called for increased efforts to develop new treatments and a boost in gonorrhea surveillance in order to identify emerging patterns of antibiotic resistance in gonorrhea as they occur.

Over time, gonorrhea has developed resistance to several antibiotics. The CDC currently recommends dual therapy of cephalosporins with either azithromycin or doxycycline. Treatment options would become substantially limited if gonorrhea becomes resistant to cephalosporins, the researchers warned.

Left untreated, gonorrhea can cause infertility in women and increase the risk of infection with HIV, the virus that causes AIDS, for men and women.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about gonorrhea.

-- Robert Preidt

SOURCE: U.S. Centers for Disease Control and Prevention, news release, July 7, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Lists of Prescription Meds Side Effects Keep Growing: Study
2. Gynecologic cancer expert helps pinpoint best treatment for fast-growing gestational tumors
3. HIV Kids Growing Up Well, Study Finds
4. Insights gained from growing cold-causing virus on sinus tissue
5. Outgrowing Milk Allergy May Take Some Babies Longer Than Expected
6. Kids Growing Up on Farms Less Likely to Have Asthma
7. Study examines earlier use of heart pumps in growing group of heart failure patients
8. Caffeinated alcoholic beverages -- a growing public health problem
9. Awareness of COPD Growing, But More Lung Testing Urged
10. ASN leads efforts to address growing crisis in kidney care
11. Scientists Report Early Success in Growing Mini Liver in Lab
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gonorrhea's Growing Resistance to Antibiotics Concerns CDC
(Date:3/27/2017)... ... 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, ... and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... second annual venture competition ignites bold ideas by providing women access to the tools, ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the leading multimedia ... medicine, announces the launch of Veterinarian’s Money Digest™, a business and financial resource ... of American Veterinarian™. , “We look forward to launching Veterinarian’s Money ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... products enables researchers to pursue the recent RNA methylation “gold rush” with their ... light of the newfound characteristics of N6-methyladenosine, or m6A , RNA methylation ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... According to ... prostate cancer, including all stages, is more than 95%. Once the cancer spreads to ... less than 30%. To find out how to avoid this latter group, tune in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending ... the pending litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil ... am thrilled to announce that we have now reached a settlement agreement regarding ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Twist Bioscience, a ... synthesis, today announced that it raised an additional $33 ... of $166 million. "It is an ... expand our reach and continue to deliver industry-leading gene ... market segments," commented Emily M. Leproust, Ph.D., CEO of ...
(Date:3/27/2017)... 2017 Cota Healthcare, the leading ... medicine, today announced the signing of a ... to help improve clinical and cost outcomes ... part of this agreement, which expands significantly ... January 2016, teams from across Novartis Pharmaceuticals ...
(Date:3/27/2017)...   Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company ... the Company,s Chief Operating Officer, is scheduled to present a corporate ... 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 ... ... 24th Annual Future Leaders in Biotech Industry – Friday, April 7, ...
Breaking Medicine Technology: